Ignite Creation Date:
2024-05-05 @ 9:41 PM
Last Modification Date:
2024-10-26 @ 10:08 AM
Study NCT ID:
NCT00944541
Status:
COMPLETED
Last Update Posted:
2011-12-22
First Post:
2009-07-22
Brief Title:
Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Organization:
French National Agency for Research on AIDS and Viral Hepatitis
Study Overview
Official Title:
Pilot Study Evaluating Maraviroc CelsentriIntensification Benefit in HIV Infected Patients Presenting Insufficient Immune Restoration Despite Controlled Viral Load With Antiretroviral Treatment ANRS 145 MARIMUNO
Status:
COMPLETED
Status Verified Date:
2011-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
145 MARIMUNO
Brief Summary:
This pilot study aims to evaluate Maraviroc intensification strategy during 24 weeks in HIV infected patients under efficient CV 50 cpmL controlled antiretroviral therapy 6 months and uncompleted immune restoration CD4350 cellsmL and CD4 earning 100 cellsmL during last 24 months
The study will include 60 patients whose follow up is carried out for 48 weeks recruitment period will be maintained for 12 months
The study will include 60 patients whose follow up is carried out for 48 weeks recruitment period will be maintained for 12 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ANRS 145 MARIMUNO | None | None | None |